Name: INmune Bio, Inc. (INMB) Balance Sheet
Creator: FinSpry

INmune Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for INmune Bio, Inc. (INMB) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	20.92	35.85	52.15	74.81	21.97	7.00
Cash & Short-Term Investments	20.92	35.85	52.15	74.81	21.97	7.00
Accounts Receivable	1.41	2.44	8.46	5.50	1.80	0.08
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.33	1.51	4.03	2.28	0.22	0.57
Total Current Assets	22.66	39.94	64.68	82.61	23.99	7.74
Non-Current Assets
Property, Plant & Equipment (Net)	0.31	0.41	0.51	0.73	0.16	0.19
Intangible Assets	16.51	16.51	16.51	16.51	16.51	0.00
Other Non-Current Assets	0.08	0.13	0.10	0.10	0.00	0.03
Total Non-Current Assets	16.90	17.06	17.12	17.34	16.67	16.73
Total Assets	39.56	57.00	81.80	99.95	40.66	24.47
Current Liabilities
Accounts Payable	6.54	7.94	5.22	3.81	1.52	0.69
Short-Term Debt	0.14	9.92	5.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	9.92	5.00	0.00	0.00	0.00
Accrued Liabilities	0.03	0.04	0.01	0.01	0.03	0.00
Other Current Liabilities	0.52	0.49	0.62	0.47	0.19	0.00
Total Current Liabilities	7.22	18.47	10.92	4.36	1.78	0.70
Non-Current Liabilities
Long-Term Debt	0.24	0.40	9.70	14.46	0.13	0.16
Other Non-Current Liabilities	0.00	0.00	0.55	0.20	0.00	0.00
Total Non-Current Liabilities	0.24	0.40	10.77	15.36	0.13	0.16
Total Liabilities	7.47	18.86	21.69	19.72	1.90	0.86
Stockholders' Equity
Common Stock	0.02	0.82	0.02	0.02	0.01	0.00
Retained Earnings	-163.10	-121.02	-91.01	-63.72	-33.38	-21.28
Accumulated Other Comprehensive Income	-0.58	-0.80	-0.70	0.00	0.01	-0.01
Additional Paid-in Capital	195.75	159.14	151.80	143.92	72.11	44.83
Shares Outstanding	22.28	17.95	17.95	17.84	0.00	0.00
Total Stockholders' Equity	32.10	38.14	60.10	80.23	38.75	23.61
Total Liabilities & Equity	39.56	57.00	81.80	99.95	40.66	24.47